FDA approved Luxturna, first gene therapy for an inherited disease
Dated 19 December 2017: FDA approved Luxturna, first gene therapy for an inherited disease. In the causal graph this event strengthens the driver Biotechnology Innovation.
Who was responsible
Contribution type and responsibility level for each recorded actor — not sole-author shorthand.
No public contributors are listed for this fact.
What changed
Fact → Driver → Indicator. Relationship strength orders the paths; it is not the observed indicator movement.
- FactFDA approved Luxturna, first gene therapy for an inherited disease
- strengthensDriverBiotechnology Innovation
provisional weight · verified
Causal path
How this event connects to drivers and indicators in the graph.
- FactFDA approved Luxturna, first gene therapy for an inherited disease
- strengthensDriverBiotechnology Innovation
Cite this page
Factrail. (2026). FDA approved Luxturna, first gene therapy for an inherited disease. Factrail. https://factrail.ai/facts/fda-luxturna-rpe65-gene-therapy-approval-2017
https://factrail.ai/facts/fda-luxturna-rpe65-gene-therapy-approval-2017
Accessed 15 October 2026.
By the Factrail desk · Method: how we source and score · Last reviewed
Dispute this factNamed here, or represent someone who is? Request a right of reply.